These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 10933811)
21. Sequence- and region-specificity of oxaliplatin adducts in naked and cellular DNA. Woynarowski JM; Chapman WG; Napier C; Herzig MC; Juniewicz P Mol Pharmacol; 1998 Nov; 54(5):770-7. PubMed ID: 9804612 [TBL] [Abstract][Full Text] [Related]
22. Postlabeling detection of DNA adducts of antitumor alkylating agents. Zhou GH; Teicher BA; Frei E Cancer Chemother Pharmacol; 1996; 38(1):71-80. PubMed ID: 8603455 [TBL] [Abstract][Full Text] [Related]
23. Determination of the structural role of the linking moieties in the DNA binding of adozelesin. Cameron L; Thompson AS Biochemistry; 2000 May; 39(17):5004-12. PubMed ID: 10819964 [TBL] [Abstract][Full Text] [Related]
24. Induction by adozelesin and hydroxyurea of origin recognition complex-dependent DNA damage and DNA replication checkpoints in Saccharomyces cerevisiae. Weinberger M; Trabold PA; Lu M; Sharma K; Huberman JA; Burhans WC J Biol Chem; 1999 Dec; 274(50):35975-84. PubMed ID: 10585487 [TBL] [Abstract][Full Text] [Related]
25. A model for the T-antigen-induced structural alteration of the SV40 replication origin based upon experiments with specific probes for bent, straight, and unwound DNA. Han FX; Hurley LH Biochemistry; 1996 Jun; 35(24):7993-8001. PubMed ID: 8672503 [TBL] [Abstract][Full Text] [Related]
26. Mutation spectra induced by adozelesin in the supF gene of human XP-A fibroblasts. Lee SY; Pfeifer GP; Lee CS Arch Pharm Res; 2010 Apr; 33(4):633-6. PubMed ID: 20422374 [TBL] [Abstract][Full Text] [Related]
27. Determination of the structural role of the internal guanine-cytosine base pair in recognition of a seven-base-pair sequence cross-linked by bizelesin. Thompson AS; Fan JY; Sun D; Hansen M; Hurley LH Biochemistry; 1995 Sep; 34(35):11005-16. PubMed ID: 7669758 [TBL] [Abstract][Full Text] [Related]
28. Adozelesin triggers DNA damage response pathways and arrests SV40 DNA replication through replication protein A inactivation. Liu JS; Kuo SR; McHugh MM; Beerman TA; Melendy T J Biol Chem; 2000 Jan; 275(2):1391-7. PubMed ID: 10625690 [TBL] [Abstract][Full Text] [Related]
29. Activation of budding yeast replication origins and suppression of lethal DNA damage effects on origin function by ectopic expression of the co-chaperone protein Mge1. Trabold PA; Weinberger M; Feng L; Burhans WC J Biol Chem; 2005 Apr; 280(13):12413-21. PubMed ID: 15647270 [TBL] [Abstract][Full Text] [Related]
30. Synergistic and additive combinations of several antitumor drugs and other agents with the potent alkylating agent adozelesin. Smith KS; Folz BA; Adams EG; Bhuyan BK Cancer Chemother Pharmacol; 1995; 35(6):471-82. PubMed ID: 7533669 [TBL] [Abstract][Full Text] [Related]
31. The A/T-specific DNA alkylating agent adozelesin inhibits Plasmodium falciparum growth in vitro and protects mice against Plasmodium chabaudi adami infection. Yanow SK; Purcell LA; Spithill TW Mol Biochem Parasitol; 2006 Jul; 148(1):52-9. PubMed ID: 16597469 [TBL] [Abstract][Full Text] [Related]
32. Southern blot analysis of T-cell receptor gene rearrangements in cynomolgus monkeys, and identification of a progenitor cell HPRT mutation. Mattano SS; Zimmer DM; Harbach PR; Hunter TC; Aaron CS Environ Mol Mutagen; 1995; 26(2):119-26. PubMed ID: 7556108 [TBL] [Abstract][Full Text] [Related]
33. Manipulative interplay of two adozelesin molecules with d(ATTAAT)â‚‚achieving ligand-stacked Watson-Crick and Hoogsteen base-paired duplex adducts. Hopton SR; Thompson AS Biochemistry; 2011 May; 50(19):4143-54. PubMed ID: 21469674 [TBL] [Abstract][Full Text] [Related]
34. Does the antitumor cyclopropylpyrroloindole antibiotic CC-1065 cross-link DNA in tumor cells? Skladanowski A; Koba M; Konopa J Biochem Pharmacol; 2001 Jan; 61(1):67-72. PubMed ID: 11137711 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of RecBCD enzyme by antineoplastic DNA alkylating agents. Dziegielewska B; Beerman TA; Bianco PR J Mol Biol; 2006 Sep; 361(5):898-919. PubMed ID: 16887143 [TBL] [Abstract][Full Text] [Related]
36. Detection of sequence-specific antitumor alkylating agent DNA damage from cells treated in culture and from a patient. Bubley GJ; Ogata GK; Dupuis NP; Teicher BA Cancer Res; 1994 Dec; 54(24):6325-9. PubMed ID: 7987822 [TBL] [Abstract][Full Text] [Related]
37. Lethality, DNA alkylation, and cell cycle effects of adozelesin (U-73975) on rodent and human cells. Bhuyan BK; Smith KS; Adams EG; Petzold GL; McGovren JP Cancer Res; 1992 Oct; 52(20):5687-92. PubMed ID: 1394193 [TBL] [Abstract][Full Text] [Related]
38. Adozelesin, a potent new alkylating agent: cell-killing kinetics and cell-cycle effects. Bhuyan BK; Smith KS; Adams EG; Wallace TL; Von Hoff DD; Li LH Cancer Chemother Pharmacol; 1992; 30(5):348-54. PubMed ID: 1505072 [TBL] [Abstract][Full Text] [Related]
39. DNA interstrand cross-links induced by the cyclopropylpyrroloindole antitumor agent bizelesin are reversible upon exposure to alkali. Lee CS; Gibson NW Biochemistry; 1993 Sep; 32(35):9108-14. PubMed ID: 8369282 [TBL] [Abstract][Full Text] [Related]
40. Measuring gene-specific nucleotide excision repair in human cells using quantitative amplification of long targets from nanogram quantities of DNA. Van Houten B; Cheng S; Chen Y Mutat Res; 2000 Jul; 460(2):81-94. PubMed ID: 10882849 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]